N1-Methylpseudouridine for Cancer mRNA Assays
2026-08-12
Use N1-Methylpseudouridine to build higher-expression, lower-stress mRNA controls for cancer-cell rescue, reporter, adhesion, and anoikis assays. This workflow connects modified-nucleoside translation control with the PCMT1 metastasis biology identified by a genome-wide CRISPR screen, while keeping causal interpretation experimentally disciplined.
LY2109761: From TGF-β Mechanism to Translation
2026-08-11
A translational perspective on LY2109761, a TGF-β receptor type I and II dual inhibitor, linking receptor-proximal kinase blockade and Smad2/3 signaling to cancer, radiation response, fibrosis, and experimental design.
Cy3 Goat Anti-Rabbit IgG: From MPP7 to Translation
2026-08-10
A translational strategy for converting MPP7, EMT, Wnt/β-catenin, and epithelial polarity biology into reproducible fluorescence evidence using a Cy3-conjugated secondary antibody.
Irinotecan Workflows for Colorectal Cancer Research
2026-08-09
Build more reproducible CPT-11 experiments by linking prodrug activation, topoisomerase I–associated DNA damage, and cell death with gut–liver toxicity endpoints. This practical guide covers 2D assays, advanced tumor models, xenograft interpretation, and troubleshooting for Irinotecan-based colorectal cancer research.
EdU Imaging Kits (488) for S-Phase Analysis
2026-08-08
EdU Imaging Kits (488) convert newly synthesized DNA into a bright 6-FAM signal without the harsh denaturation required by BrdU workflows. This makes the kit useful for linking HAUS1 perturbation to S-phase activity in hepatocellular carcinoma models while preserving morphology and antigen-binding sites for multiplex imaging.
Spleen-Targeted Neoantigen mRNA Vaccine in HCC
2026-08-07
Lin et al. developed a spleen-targeted neoantigen mRNA vaccine that produced strong antitumor activity in an orthotopic hepatocellular carcinoma model. The study links efficacy to neoantigen-specific ISG15-positive CD8-positive T cells, GZMA-F2R signaling, and tertiary lymphoid structure formation, providing a mechanistic framework for improving cancer mRNA vaccine design.
Isoproterenol Sulfate Dihydrate: Decoding Human Pacemaker Ma
2026-08-07
Explore the advanced role of Isoproterenol sulfate dihydrate in dissecting neuro-cardiac signaling and pacemaker maturation in human assembloid systems. This in-depth analysis uniquely bridges molecular mechanisms, protocol optimization, and translational assay design.
PDX1 Mutations, m6A Methylation, and Pancreatic Agenesis in
2026-08-06
Zhang et al. present a pioneering nonhuman primate model revealing how PDX1 mutations cause pancreatic agenesis and altered m6A RNA methylation, providing rare molecular insight into MODY4 pathogenesis. These findings highlight the translational relevance of epigenetic regulation in diabetes research and underscore the value of advanced animal models for preclinical study.
Gepotidacin vs Nitrofurantoin: Phase 3 UTI Trials and Implic
2026-08-06
The EAGLE-2 and EAGLE-3 trials compared oral gepotidacin, a novel triazaacenaphthylene antibiotic, with nitrofurantoin for uncomplicated urinary tract infections (UTIs) in females. Gepotidacin demonstrated non-inferior—and in one study, superior—therapeutic efficacy with acceptable safety, indicating its promise for treating UTIs in the context of rising antimicrobial resistance.
40-Hz Light Flicker Enhances Retinal Amyloid Clearance via M
2026-08-05
This study demonstrates that 40-Hz light flicker upregulates MHC-II expression in retinal microglia, enhancing amyloid-β clearance and retinal function in aged mice. The findings highlight a non-invasive strategy for modulating immune-mediated waste removal in age-related retinal degeneration.
CTOP: Precision μ-Opioid Receptor Antagonist in Pain Researc
2026-08-05
CTOP empowers researchers to dissect μ-opioid receptor signaling with high specificity, enabling clear differentiation of central versus peripheral opioid effects. This article delivers actionable workflows, troubleshooting strategies, and advanced applications to maximize CTOP's impact in neuropharmacology and pain mechanism research.
S1P/S1PR3 Axis Drives Neuronal Apoptosis After Intracerebral
2026-08-04
The reference study uncovers a mechanistic link between Sphingosine-1-phosphate (S1P) signaling through S1PR3 and neuronal apoptosis after acute intracerebral hemorrhage (ICH), mediated by the TNF-α/caspase-3 pathway. These findings clarify a key process in secondary brain injury and highlight S1PR3 as a potential neuroprotective target.
Bobcat339: Cytosine Structure-Based TET Enzyme Inhibitor in
2026-08-04
Bobcat339 enables researchers to modulate DNA methylation with precision, making it a cornerstone for epigenetic regulatory mechanism studies in complex disease models. This guide delivers actionable protocols, troubleshooting insights, and strategic applications for maximizing research impact with this specialized TET enzyme inhibitor.
Mc-Val-Cit-PABC-PNP: Technical Guide for ADC Synthesis
2026-08-03
Mc-Val-Cit-PABC-PNP addresses the need for a cathepsin-cleavable ADC peptide linker in antibody-drug conjugate workflows requiring precise lysosomal payload release. It is intended for organic solvent-based research applications and should not be used in aqueous, diagnostic, or therapeutic contexts.
Antibacterial Drug Use and Resistance in Psychiatric Hospita
2026-08-03
This study delivers a comprehensive, retrospective analysis of antibacterial drug utilization and bacterial resistance in a psychiatric hospital during the 2022 COVID-19 epidemic. Its findings reveal that while antibiotic consumption was lower than regional and national averages, bacterial resistance patterns remain a critical concern, emphasizing the ongoing need for targeted antimicrobial stewardship in psychiatric settings.
462 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page